On March 17th, Times magazine released an article informing the public that Becton Dickinson (BD) is seeking emergency FDA approval for a two-hour coronavirus test. If approved, this would save hospitals up to two weeks of time in diagnosing a patient. Not only is this positive news, but it may prevent an increasingly growing influx of patients in hospitals worldwide.
The article states that this method has already been utilized overseas. BD’s hope is that FDA’s emergency approval will allow its implementation in the United States.
“According to [BD] CEO Tom Polen, the test has already been used in China, including at the pandemic’s epicenter in Wuhan, and in Europe. The company has partnered with Alabama-based biotech company BioGX and asked the FDA for approval to use its test in the U.S. under the agency’s Emergency Use Authorization, which allows expedited review of new tests under emergency circumstances such as a pandemic.”
Alice Park for Times Magazine
BD states they’re currently working on developing another test that cuts the results delivery time in half. The test would be sixty minutes long, handheld, and available to retail clinics nationwide.
Read the full article here: https://time.com/5804222/two-hour-coronavirus-test/
Washington Consular Services is immensely proud of BD’s perseverance in preventing the spread of the COVID-19 virus, and by being their Apostille and Legalization partner.